Anna L. de Goede

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption

Sabine Allard, Brenda De Keersmaecker, Anna L. de Goede et al. · Clinical Immunology · 2011 · 119 citations

Life Sciences, Immunology, Infectious Diseases +17

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

Harm Westdorp, Jeroen H. A. Creemers, Inge M. van Oort et al. · Journal for ImmunoTherapy of Cancer · 2019 · 113 citations · Full text

Medicine, Immunology, Oncology +17

Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM:A Phase I Clinical Trial Including Correlative Studies

Erik H.P. van Putten, David P. Noske, C. B. H. W. Lamers et al. · Digital Commons@Becker (Washington University School of Medicine) · 2022 · 74 citations · Full text

Medicine, Neurology, Oncology +17

What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings

Renske M.T. ten Ham, Anke M. Hövels, Jarno Hoekman et al. · Cytotherapy · 2020 · 67 citations · Full text

Engineering, Biomedical Engineering, Manufacturing Engineering +17

Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma

Kalijn F. Bol, Thomas van den Bosch, Gerty Schreibelt et al. · Ophthalmology · 2016 · 48 citations · Full text

Medicine, Immunology, Oncology +14